Form 8-K · Current Report · Filed 2026-08-18
GE HealthCare Appoints New Chief Financial Officer
GE HealthCare Technologies Inc. announced on August 13, 2026, the appointment of William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. Mr. Grogan, previously the Executive Vice President and CFO of Xylem Inc., will succeed George A. Newcomb, who will continue in his role as Controller and Chief Accounting Officer. The Talent, Culture, and Compensation Committee approved Mr. Grogan's compensation package, which includes an annual base salary of $900,000, a target annual bonus of 100% of base salary, and various long-term incentive awards totaling $7,600,000. Additionally, Mr. Grogan will receive a cash sign-on payment of $550,000 and a one-time equity award valued at $4,000,000.
- Filer
- Ge Healthcare Technologies Inc. GEHC · NASDAQ
- Filed
- Accession
- 0001932393-26-000050
- CIK
- 0001932393
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$72.37
Since filing
+0.0%
Latest close
$72.37
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from GEHC reporting the same item, with the next session's move:
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Never miss another GEHC filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.